The role of E2F1 in the development of hypertrophic cardiomyopathy

International Journal of Clinical and Experimental Pathology

Volumn 4, Issue 5, 2011, Pages 521-525

  Wolfram, Julie A ^a   Liner, Anna ^a   Richardson, Sandy L ^a   Zhu, Xiongwei ^a   Smith, Mark A ^a   Hoit, Brian D ^a   Lee, Hyoung gon ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angiotensin II; Cardiac hypertrophy; Cardiomyopathy; Cell cycle; E2F1; Isoproterenol

Indexed keywords

ANGIOTENSIN II; ATRIAL NATRIURETIC FACTOR; CARDIOTONIC AGENT; E2F1 PROTEIN, MOUSE; ISOPRENALINE; MESSENGER RNA; TRANSCRIPTION FACTOR E2F1; VASOCONSTRICTOR AGENT;

ANIMAL; APOPTOSIS; ARTICLE; CARDIOMEGALY; CELL CYCLE; CHEMICALLY INDUCED DISORDER; CYTOLOGY; DRUG ANTAGONISM; GENE EXPRESSION REGULATION; GENETICS; HEART MUSCLE CELL; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MALE; METABOLISM; MOUSE; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

ANGIOTENSIN II; ANIMALS; APOPTOSIS; ATRIAL NATRIURETIC FACTOR; CARDIOMEGALY; CARDIOMYOPATHY, HYPERTROPHIC; CARDIOTONIC AGENTS; CELL CYCLE; E2F1 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION; HUMANS; ISOPROTERENOL; MALE; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MYOCYTES, CARDIAC; RNA, MESSENGER; SIGNAL TRANSDUCTION; VASOCONSTRICTOR AGENTS;

EID: 80055033410     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Polager S and Ginsberg D. E2F - at the crossroads of life and death. Trends Cell Biol 2008; 18: 528-535.
2. Johnson DG, Schwarz JK, Cress WD and Nevins JR. Expression of transcription factor E2F1 induces quiescent cells to enter S phase. Nature 1993; 365: 349-352.
3. Shirodkar S, Ewen M, DeCaprio JA, Morgan J, Livingston DM and Chittenden T. The transcription factor E2F interacts with the retinoblastoma product and a p107-cyclin A complex in a cell cycle-regulated manner. Cell 1992; 68: 157-166.
4. Vara D, Bicknell KA, Coxon CH and Brooks G. Inhibition of E2F abrogates the development of cardiac myocyte hypertrophy. J Biol Chem 2003; 278: 21388-21394.
5. Wohlschlaeger J, Schmitz KJ, Takeda A, Takeda N, Vahlhaus C, Stypmann J, Schmid C and Baba HA. Reversible regulation of the retinoblastoma protein/E2F-1 pathway during "reverse cardiac remodelling" after ventricular unloading. J Heart Lung Transplant 2010; 29: 117-124.
6. Agah R, Kirshenbaum LA, Abdellatif M, Truong LD, Chakraborty S, Michael LH and Schneider MD. Adenoviral delivery of E2F-1 directs cell cycle reentry and p53-independent apoptosis in postmitotic adult myocardium in vivo. J Clin Invest 1997; 100: 2722-2728.
7. Oliveira EM and Krieger JE. Chronic betaadrenoceptor stimulation and cardiac hypertrophy with no induction of circulating renin. Eur J Pharmacol 2005; 520: 135-141.
8. Field SJ, Tsai FY, Kuo F, Zubiaga AM, Kaelin WG, Jr., Livingston DM, Orkin SH and Greenberg ME. E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell 1996; 85: 549-561.
9. Lee HG, Chen Q, Wolfram JA, Richardson SL, Liner A, Siedlak SL, Zhu X, Ziats NP, Fujioka H, Felsher DW, Castellani RJ, Valencik ML, McDonald JA, Hoit BD, Lesnefsky EJ and Smith MA. Cell cycle re-entry and mitochondrial defects in myc-mediated hypertrophic cardiomyopathy and heart failure. PLoS One 2009; 4: e7172.
10. Faulx MD, Ernsberger P, Vatner D, Hoffman RD, Lewis W, Strachan R and Hoit BD. Straindependent beta-adrenergic receptor function influences myocardial responses to isoproterenol stimulation in mice. Am J Physiol Heart Circ Physiol 2005; 289: H30-36.
11. Chellappan SP, Hiebert S, Mudryj M, Horowitz JM and Nevins JR. The E2F transcription factor is a cellular target for the RB protein. Cell 1991; 65: 1053-1061.
12. Tsai SY, Opavsky R, Sharma N, Wu L, Naidu S, Nolan E, Feria-Arias E, Timmers C, Opavska J, de Bruin A, Chong JL, Trikha P, Fernandez SA, Stromberg P, Rosol TJ and Leone G. Mouse development with a single E2F activator. Nature 2008; 454: 1137-1141.